BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19404212)

  • 1. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V; Krug LM; Laser B; Hudka K; Flores R; Rusch VW; Rosenzweig KE
    J Thorac Oncol; 2009 Jun; 4(6):746-50. PubMed ID: 19404212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.
    Allen AM; Den R; Wong JS; Zurakowski D; Soto R; Jänne PA; Zellos L; Bueno R; Sugarbaker DJ; Baldini EH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1366-74. PubMed ID: 17674974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
    Hill-Kayser CE; Avery S; Mesina CF; James P; Friedberg JS; Cengel K; Lin LL; Hahn SM; Rengan R
    J Thorac Oncol; 2009 Nov; 4(11):1431-7. PubMed ID: 19745767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Gomez DR; Hong DS; Allen PK; Welsh JS; Mehran RJ; Tsao AS; Liao Z; Bilton SD; Komaki R; Rice DC
    J Thorac Oncol; 2013 Feb; 8(2):238-45. PubMed ID: 23247629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
    Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
    Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
    Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
    Doyle LA; Showalter TN; Werner-Wasik M; Weksler B; Xiao Y; Yu Y; Macrone A; Liu H; Harrison A
    Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
    Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
    Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series.
    Tonoli S; Vitali P; Scotti V; Bertoni F; Spiazzi L; Ghedi B; Buonamici FB; Marrazzo L; Guidi G; Meattini I; Bastiani P; Amichetti M; Schwarz M; Magrini SM
    Radiother Oncol; 2011 Nov; 101(2):311-5. PubMed ID: 22079529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma.
    Chi A; Liao Z; Nguyen NP; Howe C; Gomez D; Jang SY; Komaki R
    J Thorac Oncol; 2011 Jun; 6(6):1132-41. PubMed ID: 21532502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    Rusch VW; Rosenzweig K; Venkatraman E; Leon L; Raben A; Harrison L; Bains MS; Downey RJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):788-95. PubMed ID: 11581615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.